Page last updated: 2024-11-07

prednisone and Opportunistic Infections

prednisone has been researched along with Opportunistic Infections in 123 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

ExcerptRelevanceReference
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections."7.76Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010)
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)."6.76Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011)
" Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab."4.89Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease. ( Fedorak, RN; Ma, C; Walters, B, 2013)
" Clinical studies, registries, and case reports warn of the increased risk of infections, particularly opportunistic infections; however, already in the steroid monotherapy era, patients are at risk because it is accepted that a patient should be considered immunosuppressed when receiving a daily dose of 20 mg of prednisone for 2 weeks."4.88Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary. ( de Ridder, L; Dias, JA; Escher, JC; Fell, J; Kolacek, S; Koletzko, S; Malmborg, P; Misak, Z; Rahier, JF; Veereman-Wauters, G; Veres, G, 2012)
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections."3.76Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010)
" The authors report a case of histoplasmosis presenting with signs of severe hypercalcemia and renal failure in a patient on infliximab for approximately three years in combination with low dosages of methotrexate and prednisone."3.76Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy. ( Kamili, Qu; Menter, A, 2010)
" She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis."3.76Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. ( Battegay, M; Trendelenburg, M; Vetter, M, 2010)
" In our patient, both polymyositis and steroid therapy were predisposing factors of cutaneous leishmaniasis onset; prednisone therapy has been postulated to be associated with immune dysfunction leading to: reduced blood T cells' levels (CD4 et CD8) as well as decreased cytokine synthesis (e."3.73[Cutaneous leishmaniasis in polymyositis]. ( Bernet, J; Courville, P; Favennec, L; Fevre, C; Levesque, H; Marie, I, 2006)
" After two weeks of prednisone therapy, the patient developed prolonged fever, which was caused by CMV disseminated disease, with prompt clinical recovery after ganciclovir administration."3.72Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. ( Aoki, V; Casals, DS; Correa, MC; Leite, OH; Maruta, CW; Nunes, Ede A; Rivitti, EA; Santi, CG; Simonsen Nico, MM, 2003)
" A 52 year old woman is reported who was on long term treatment with chlorambucil and taking a short course of prednisone for familial CLL before she developed progressive dyspnoea, and P carinii pneumonia was diagnosed in bronchoalveolar lavage fluid."3.72Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. ( Halter, J; Hechelhammer, L; Himmelmann, A; Vavricka, SR, 2004)
"Hypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and prednisone."3.68De novo hypertension after liver transplantation. ( Textor, SC, 1993)
" He had the nephrotic syndrome for which he was on 60 mg prednisone daily."3.68Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole. ( Coley, KE; Duffill, MB, 1993)
"Seventeen cases of pneumonia occurring in renal transplantation patients treated with cyclosporine-prednisone immunosuppression were analyzed with regard to the organisms involved, time of occurrence after transplantation, clinical course, and radiographic findings."3.67Pulmonary infections in renal transplantation patients treated with cyclosporine. ( Amend, WJ; Moore, EH; Webb, WR, 1988)
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)."2.76Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011)
"Nocardiosis is an uncommon opportunistic infection seen in immunocompromised patients or those with a dysfunctional immune system."2.72Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review. ( Chen, C; Chen, M; He, Y; Li, X; Liang, M; Liu, S; Luo, N; Singh, S; Tan, S; Yang, W, 2021)
"MPA Cpredose and MPA AUC are significantly related to the incidence of biopsy-proven rejection after kidney transplantation, whereas MMF dose is significantly related to the occurrence of adverse events."2.69A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. ( de Fijter, JW; Hale, MD; Hené, RJ; Hilbrands, LB; Navarro, MT; Nicholls, AJ; Squifflet, JP; van Gelder, T; Vanrenterghem, Y; Verpooten, GA; Weimar, W, 1999)
"Evans syndrome is a rare disorder characterized by combined autoimmune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA)."2.41Allogeneic stem cell transplantation for Evans syndrome. ( Burt, RK; Miranda, M; Oyama, Y; Papadopoulos, EB; Traynor, AE, 2001)
"A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology."2.38[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991)
"Although rabbit anti-thymocyte globulin (rATG) is commonly used as induction therapy for kidney transplantation, dosing is not standardized."1.42Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. ( Lee, E; Lee, S; Park, JM; Pennington, CA; Sindelar, J; Tischer, SM, 2015)
"These infections included four cases of pneumocystosis, two cases of candidiasis, two cases of aspergillosis, two cases of cryptococcosis and one case of mucormycosis."1.39Invasive fungal infections in renal transplant recipients: about 11 cases. ( Ayadi, A; Charffedine, K; Cheikhrouhou, F; Guidara, R; Hachicha, J; Makni, F; Néji, S; Sellami, H; Trabelsi, H; Yaich, S, 2013)
"Crusted Norwegian scabies is an extremely rare hyperkeratotic variant of scabies infestation."1.37Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis. ( Aractingi, S; Baccouche, K; Berenbaum, F; Guegan, S; Sellam, J, 2011)
"We report on a patient with Pneumocystis jirovecii pneumonia who developed fever, rash, eosinophilia and hepatitis 10 days after initiation of a therapy with sulfamethoxazole and trimethoprim."1.36[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)]. ( Derungs, A; Kummer, O; Rätz Bravo, AE, 2010)
"Kaposi's sarcoma is a vascular tumor caused by human herpesvirus-8 infection."1.36Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis. ( de Francisco, R; Fernández-García, MS; García-Pravia, C; Gutiérrez-Corral, N; Riestra, S; Rodrigo, L; Rodríguez, JI; Rodríguez-Peláez, M, 2010)
"She simultaneously developed pulmonary nocardiosis as well as a soft tissue infection and osteomyelitis by mycobacterium abscessus."1.35[Pulmonary nodules in a patient on long-term steroid treatment]. ( Bürgi, U; Hurni, Ch; Perrig, M; Rauch, A; Schoenenberger, AW; Trost, N, 2008)
"We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy."1.35Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. ( Kovacs, JA; Masur, H, 2009)
"Strongyloidiasis is epidemic in tropical and subtropical regions where the regional prevalence may exceed 25%."1.34Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. ( Dincer, HE; Krishnamurthy, R; Whittemore, D, 2007)
" Diagnosis was based on the very typical ocular feature combined with a positive blood or vitreous culture."1.33[Endogenous Candida endophthalmitis combined with severe general diseases]. ( Stoffelns, BM, 2005)
"Lymphocytopenia has been reported in patients with connective tissue diseases, including dermatomyositis (DM)."1.32Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. ( Bachelez, H; de la Salmonière, P; Dubertret, L; Fouéré, S; Lebbe, C; Morel, P; Rabian, C; Viguier, M, 2003)
"A 48 year old patient with active Crohn's disease presented with bilateral nodules over his lungs resembling malignant metastasis."1.32Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. ( Majoor, CJ; Schreurs, AJ; Weers-Pothoff, G, 2004)
"The other patient presented with upper gastrointestinal hemorrhage from a bleeding duodenal ulcer."1.31[Atypical cytomegalovirus in renal transplantation: a new form of presentation]. ( Campistol, JM; Cofán, F; Esforzado, N; Llach, J; Oppenheimer, F; Pérez-Valentín, MA; Solé, M, 2002)
" Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities."1.31A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. ( Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K, 2001)
"We describe the clinical presentation, treatment of Kaposi's sarcoma skin lesions in an immunosuppressed patient with bullous pemphigoid."1.30Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. ( Gaspari, AA; Marchese, S; Powell, D; Rady, PL; Tyring, SK, 1997)
"402 patients with chronic lymphocytic leukemia not previously treated or treated with chlorambucil (with or without prednisone) who received fludarabine (30 mg/m2 of body surface area per day for 5 days) with or without prednisone at 4-week intervals."1.30Infections in patients with chronic lymphocytic leukemia treated with fludarabine. ( Anaissie, EJ; Kantarjian, H; Keating, MJ; Kontoyiannis, DP; Lerner, S; O'Brien, S; Robertson, L, 1998)
"Disseminated histoplasmosis is an unusual complication in endemic areas and has been reported in patients with an immunodeficient state, either from human immunodeficiency virus (HIV) infection or transplantation."1.30Disseminated histoplasmosis and Wegener's granulomatosis. ( Manepalli, AN; Rush, L, 1998)
"A patient with systemic lupus erythematosus (SLE) developed primary subcutaneous nocardiosis during steroid and cyclophosphamide therapy for diffuse proliferative glomerulonephritis."1.30Primary subcutaneous nocardial infection in a SLE patient. ( Balbir-Gurman, A; Nahir, AM; Schapira, D, 1999)
"We report the first case of nocardiosis in a recently transplanted renal patient maintained on tacrolimus, prednisone, and mycophenolate mofetil."1.30Nocardiosis in a recently transplanted renal patient. ( Holley, JL; Reddy, SS, 1998)
"Although infectious esophagitis is usually due to infection with Candida, herpes virus, or cytomegalovirus, bacterial esophagitis is occasionally observed."1.29Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment. ( Orchard, JL; Richert, SM, 1995)
"The primary skin lesion of pemphigus vulgaris which was often fatal before the introduction of systemic glucocorticoid therapy, is a flaccid, fragile blister which can occur anywhere."1.29Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris. ( Takeshita, T, 1996)
"Most aspects of Wegener granulomatosis were similar in childhood-onset and adult-onset patients."1.29Wegener granulomatosis in children and adolescents: clinical presentation and outcome. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, R; Rottem, M, 1993)
"A further case of listeriosis has recently been described in a man who developed the infection 2 years after successful fludarabine treatment while he had a normal CD4 lymphocyte count."1.29Late listeriosis after fludarabine plus prednisone treatment. ( Girmenia, C; Mauro, FR; Rahimi, S, 1994)
"carinii pneumonia in patients with Wegener's granulomatosis."1.29Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. ( Fauci, AS; Hoffman, GS; Kerr, GS; Leavitt, RY; Ognibene, FP; Reda, D; Shelhamer, JH, 1995)
"Proven Pneumocystis carinii pneumonia (PCP) occurred in 8 (5."1.29Pneumocystis carinii pneumonia after liver transplantation in adults. ( Hayes, MJ; McCaughan, GW; Sheil, AG; Torzillo, PJ, 1994)
"We report a 49 years old woman with systemic lupus erythematosus and a WHO type IV nephropathy, treated with prednisone 1 mg/kg/day po and cyclophosphamide 1 g/month iv."1.29[Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia]. ( Guzmán, L; Neira, O; Wainstein, E, 1993)
"Temporal arteritis is a systemic necrotizing vasculitis for which the only effective treatment is systemic corticosteroids."1.29Invasive aspergillosis. A complication of treatment of temporal arteritis. ( Wiggins, RE, 1995)
"Children with malignancy have a high incidence of pneumonia and pneumonitis and death is rare if the patient does not have terminal malignant disease."1.28Pneumonia and pneumonitis in childhood malignancy. ( Eden, OB; Elton, R; Shaw, NJ, 1992)
"Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)."1.28Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991)
"The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids."1.28Wegener granulomatosis: an analysis of 158 patients. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, RS; Rottem, M; Travis, WD, 1992)
"Six had systemic lupus erythematosus and another had dermatomyositis and are described in detail."1.28Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. ( Alarcón-Segovia, D; Guerra-Bautista, G; Kraus, A, 1991)

Research

Studies (123)

TimeframeStudies, this research(%)All Research%
pre-19907 (5.69)18.7374
1990's45 (36.59)18.2507
2000's37 (30.08)29.6817
2010's29 (23.58)24.3611
2020's5 (4.07)2.80

Authors

AuthorsStudies
Shah, NJ1
Cook, MR1
Wu, T1
Lev-Ari, S1
Blackburn, MJ1
Serzan, MT1
Alaoui, A1
Ahn, J1
Atkins, MB1
Braud, A1
Wurth, S1
Leblanc, S1
Mahé, A1
Serrano, OK1
Kutzler, HL1
Rochon, C1
Radojevic, JA1
Lawlor, MT1
Hammond, JA1
Gluck, J1
Feingold, AD1
Jaiswal, A1
Wang, H1
Zhao, Y1
Zhang, X1
Si, X1
Song, P1
Xiao, Y1
Yang, X1
Song, L1
Shi, J1
Zhao, H1
Zhang, L1
Luo, N1
Tan, S1
Li, X1
Liu, S1
Singh, S1
Chen, M1
Yang, W1
He, Y1
Chen, C1
Liang, M1
Dameron, M1
Horowitz, M1
Gupta, N1
Abi Hatem, N1
Garner, O1
Ramirez-Berlioz, A1
Iardino, A1
Mocherla, S1
Bhairavarasu, K1
Mahajan, KR1
Kobayashi, T1
Ford, B1
Sekar, P1
Ma, C1
Walters, B1
Fedorak, RN1
Trabelsi, H1
Néji, S1
Sellami, H1
Yaich, S1
Cheikhrouhou, F1
Guidara, R1
Charffedine, K1
Makni, F1
Hachicha, J1
Ayadi, A1
Lauten, M1
Güttel, C1
Härtel, C1
Erdlenbruch, B1
Garrido Colmenero, C1
Arias Santiago, S1
Blasco Morente, G1
Martín Castro, A1
Leshem, YA1
Gdalevich, M1
Ziv, M1
David, M1
Hodak, E1
Mimouni, D1
Malkan, AD1
Wahid, FN1
Rao, BN1
Sandoval, JA1
Pennington, CA1
Tischer, SM1
Lee, E1
Lee, S1
Sindelar, J1
Park, JM1
Matschke, J1
Müller-Beissenhirtz, H1
Novotny, J1
Vester, I1
Hertenstein, B1
Eisele, L1
Lax, H1
Ose, C1
Dührsen, U1
Hurni, Ch1
Rauch, A1
Trost, N1
Perrig, M1
Bürgi, U1
Schoenenberger, AW1
Khellaf, M1
Godeau, B2
Rubia, MF1
Chozas, N1
García-Martos, P1
Reyes, F1
Greenberg, JD1
Reed, G1
Kremer, JM1
Tindall, E1
Kavanaugh, A1
Zheng, C1
Bishai, W1
Hochberg, MC1
Cerceo, E1
Kotloff, RM1
Hadjiliadis, D1
Ahya, VN1
Pochettino, A1
Gillespie, C1
Christie, JD1
Kovacs, JA1
Masur, H1
Jurawan, R1
de Almeida, M1
Smith, A1
Weilert, F1
Isenberg, D1
Appel, GB1
Contreras, G1
Dooley, MA1
Ginzler, EM1
Jayne, D1
Sánchez-Guerrero, J1
Wofsy, D1
Yu, X1
Solomons, N1
Kamili, Qu1
Menter, A1
Vetter, M1
Battegay, M1
Trendelenburg, M1
Bonnet, N1
Guis, S1
Drancourt, M1
Brouqui, P1
Berbis, P1
Derungs, A1
Rätz Bravo, AE1
Kummer, O1
Beksac, M1
Haznedar, R2
Firatli-Tuglular, T1
Ozdogu, H1
Aydogdu, I1
Konuk, N1
Sucak, G1
Kaygusuz, I1
Karakus, S1
Kaya, E1
Ali, R1
Gulbas, Z1
Ozet, G1
Goker, H1
Undar, L1
Rodríguez-Peláez, M1
Fernández-García, MS1
Gutiérrez-Corral, N1
de Francisco, R1
Riestra, S1
García-Pravia, C1
Rodríguez, JI1
Rodrigo, L1
Baccouche, K1
Sellam, J1
Guegan, S1
Aractingi, S1
Berenbaum, F1
Efthimiou, P1
Pokharna, H1
Kukar, M1
Hennessey, K1
Hemmaway, C1
Laverse, E1
Nicholas, M1
Nagy, Z1
Dai, W1
Dharamsi, JW1
Soliman, S1
Ricotti, C1
Gander, R1
Bergstresser, P1
Chan, J1
Kaswan, KK1
Vanikar, AV1
Feroz, A1
Patel, HV1
Gumber, M1
Trivedi, HL1
Li, F1
Jin, HZ1
Su, F1
Jia, L1
Sun, QN1
Veereman-Wauters, G1
de Ridder, L1
Veres, G1
Kolacek, S1
Fell, J1
Malmborg, P1
Koletzko, S1
Dias, JA1
Misak, Z1
Rahier, JF1
Escher, JC1
Kim, T1
Choi, SH1
Kim, SH1
Jeong, JY1
Woo, JH1
Kim, YS1
Sung, H1
Kim, MN1
Yoon, DH1
Suh, C1
Lee, SO1
Williams, MS1
Ali, N1
Nonaka, D1
Bloor, AJ1
Somervaille, TC1
MacMillan, ML1
Weisdorf, DJ1
Wagner, JE1
DeFor, TE1
Burns, LJ1
Ramsay, NK1
Davies, SM1
Blazar, BR1
Pérez-Valentín, MA1
Cofán, F1
Solé, M1
Llach, J1
Esforzado, N1
Campistol, JM1
Oppenheimer, F1
Jastrzembski, SA1
Teirstein, AS1
Herman, SD1
DePalo, LR1
Lento, PA1
Krebs, M1
Watschinger, B1
Brunner, C1
Hassl, A1
Base, W1
Seifert, B1
Favre, G1
Viguier, M1
Fouéré, S1
de la Salmonière, P1
Rabian, C1
Lebbe, C1
Dubertret, L1
Morel, P1
Bachelez, H1
Casals, DS1
Nunes, Ede A1
Maruta, CW1
Aoki, V1
Santi, CG1
Simonsen Nico, MM1
Correa, MC1
Leite, OH1
Rivitti, EA1
Gentil, B1
Cottin, V1
Girard, P1
Cordier, JF1
Vavricka, SR1
Halter, J1
Hechelhammer, L1
Himmelmann, A1
Suárez Ortega, S1
Campos-Herrero Navas, MI1
Limeres González, MA1
Díaz López, F1
Zarzalejos Andes, JM1
Arkuch Saade, ME1
Majoor, CJ1
Schreurs, AJ1
Weers-Pothoff, G1
Arunkumar, P1
Crook, T1
Ballard, J1
Tanaka, Y1
Singh, SM1
Rau, NV1
Cohen, LB1
Harris, H1
Stoffelns, BM1
Baughman, RP2
Lower, EE1
Kalkanci, A1
Kokturk, N1
Senol, E1
Acar, K1
Guzel, O1
Sancak, B1
Kustimur, S1
Rowin, J1
Amato, AA1
Deisher, N1
Cursio, J1
Meriggioli, MN1
Marie, I1
Fevre, C1
Favennec, L1
Courville, P1
Bernet, J1
Levesque, H1
Riera-Mestre, A1
de la Haba-Vacas, I1
Vidaller-Palacín, A1
Fernández-Viladrich, P1
Krishnamurthy, R1
Dincer, HE1
Whittemore, D1
Ekberg, H1
Tedesco-Silva, H1
Demirbas, A1
Vítko, S1
Nashan, B1
Gürkan, A1
Margreiter, R1
Hugo, C1
Grinyó, JM1
Frei, U1
Vanrenterghem, Y2
Daloze, P1
Halloran, PF1
Peacock, JE1
Greven, CM1
Cruz, JM1
Hurd, DD1
Faulk, CT1
Lesher, JL1
Sneller, MC1
Hoffman, GS4
Talar-Williams, C1
Kerr, GS4
Hallahan, CW3
Fauci, AS4
Wiggins, RE1
Richert, SM1
Orchard, JL1
Hayes, MJ1
Torzillo, PJ1
Sheil, AG1
McCaughan, GW1
Ognibene, FP1
Shelhamer, JH1
Reda, D1
Leavitt, RY3
Scalzini, A1
Barni, C1
Stellini, R1
Sueri, L1
Gehrke, D1
Herzum, M1
Schönian, U1
Klein, HH1
Drude, L1
Mennel, HD1
Maisch, B1
Girmenia, C1
Mauro, FR1
Rahimi, S1
Peral, V1
Vidau, P1
Herrera, J1
Rodriguez, C1
Tricas, L1
Tomé, R1
Arroyo, F1
Fang, J1
Viksman, MY1
Ebisawa, M1
Bochner, BS1
Machet, MC1
Stephanov, E1
Estève, E1
De Closets, F1
Barrabès, A1
Thérizol-Ferly, M1
Lebret, G1
Grangeponte, MC1
Vaillant, L1
Schaller, J1
Rohwedder, A1
Breier, B1
Werchau, H1
Wainstein, E1
Neira, O1
Guzmán, L1
Coutant-Perronne, V1
Le Thi Huong, D1
Guillevin, L1
Magadur, G1
De Bandt, M1
Dellion, S1
Rossert, J1
Rostoker, G1
Piette, JC1
Textor, SC1
Rottem, M2
Lebovics, R1
Duffill, MB1
Coley, KE1
Shield, CF1
Jacobs, RJ1
Wyant, S1
Das, A1
Takeshita, T1
Hedderwick, SA1
Bonilla, HF1
Bradley, SF1
Kauffman, CA1
Gaspari, AA1
Marchese, S1
Powell, D1
Rady, PL1
Tyring, SK1
Mookerjee, BP1
Vogelsang, G1
Mohammedi, I1
Vedrinne, JM1
Floccard, B1
Reverdy, ME1
Duperret, S1
Motin, J1
Pareja, JG1
Garland, R1
Koziel, H1
Poveda, F1
García-Alegría, J1
de las Nieves, MA1
Villar, E1
Montiel, N1
del Arco, A1
Reddy, SS1
Holley, JL1
Anaissie, EJ1
Kontoyiannis, DP1
O'Brien, S1
Kantarjian, H1
Robertson, L1
Lerner, S1
Keating, MJ1
Sarmiento, JM1
Munn, SR1
Paya, CV1
Velosa, JA1
Nguyen, JH1
Manepalli, AN1
Rush, L1
Schnader, J1
Pina, EM1
Glassroth, J1
Adebonojo, S1
Wang, BY1
Krishnan, S1
Isenberg, HD1
Balbir-Gurman, A1
Schapira, D1
Nahir, AM1
van Gelder, T1
Hilbrands, LB1
Weimar, W1
de Fijter, JW1
Squifflet, JP1
Hené, RJ1
Verpooten, GA1
Navarro, MT1
Hale, MD1
Nicholls, AJ1
Tirelli, U2
Vaccher, E2
Spina, M1
Carbone, A1
Martel, J1
Faisant, M1
Lebeau, B1
Pinel, C1
Feray, C1
Feuilhade, M1
Staskewitz, A1
Kirste, G1
Tönshoff, B1
Weber, LT1
Böswald, M1
Burghard, R1
Helmchen, U1
Brandis, M1
Zimmerhackl, LB1
Cornely, OA1
Pels, H1
Bethe, U1
Seibold, M1
Toepelt, K1
Soehngen, D1
Ritzkowsky, A1
Oyama, Y1
Papadopoulos, EB1
Miranda, M1
Traynor, AE1
Burt, RK1
Touahri, T1
Pulik, M1
Fezoui, H1
Genet, P1
Lionnet, F1
Louvel, D1
Facundo, C1
Diaz, JM1
Guirado, L1
Duran, F1
Herreros, MA1
Diaz, M1
Sola, R1
Vivancos, J1
Vila, M1
Serra, A1
Loscos, J1
Anguita, A1
Brownstein, S1
Vine, AK1
Rokicka-Milewska, R1
Pacholska, J1
Lukowska, K1
Paciorkiewicz, W1
Jastrzebska, M1
Shaw, NJ1
Elton, R1
Eden, OB1
Rodrigues, J1
Niederman, MS1
Fein, AM1
Pai, PB1
Monfardini, S1
Foà, R1
Gavosto, F1
Magnan, A1
Jacquème, P1
Sudan, N1
Redding, E1
Blanc, AP1
Poirier, R1
Lebovics, RS1
Travis, WD1
Kraus, A1
Guerra-Bautista, G1
Alarcón-Segovia, D1
Pohl, MA1
Lan, SP1
Berl, T1
Murdock, DK1
Lookingbill, DP1
Escobar, A1
Del Brutto, OH1
Stratta, RJ1
D'Alessandro, AM1
Armbrust, MJ1
Pirsch, JD1
Sollinger, HW1
Kalayoglu, M1
Belzer, FO1
Wiest, PM1
Flanigan, T1
Salata, RA1
Shlaes, DM1
Katzman, M1
Lederman, MM1
Moore, EH1
Webb, WR1
Amend, WJ1
Arnfred, J1
Nielsen, CM1
Spencer, ES1
Andersen, HK1
Segoloni, GP1
Messina, M1
Colla, L1
Piccoli, GB1
Triolo, G1
Vercellone, A1
Hancock, SL1
Hoppe, RT1
Horning, SJ1
Rosenberg, SA1

Clinical Trials (19)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Studies of Human Pneumocystis Infection[NCT00342589]1,500 participants (Anticipated)Observational1999-09-28Recruiting
A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.[NCT00377637]Phase 3370 participants (Actual)Interventional2005-07-31Completed
Phase III Trial Comparing Treatment With Melphalan+Prednisolon (MP) With Melphalan+Prednisolon+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma[NCT00934154]Phase 3122 participants (Actual)Interventional2006-03-31Completed
A Pilot Study on the Efficacy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive by Next Generation Flow[NCT03992170]Phase 250 participants (Anticipated)Interventional2018-12-31Recruiting
A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for[NCT05218603]100 participants (Anticipated)Observational2021-11-30Recruiting
Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors[NCT04657562]380 participants (Anticipated)Observational [Patient Registry]2020-08-01Recruiting
Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx[NCT00231764]Phase 41,760 participants Interventional2002-11-30Completed
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT04448873]Phase 430 participants (Actual)Interventional2020-07-01Completed
A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides[NCT00001473]100 participants Observational1995-03-31Completed
An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis[NCT00001256]Phase 2100 participants Interventional1990-03-31Completed
Pilot Trial for Implementation of a MPA PK Monitoring Strategy[NCT00187915]24 participants (Actual)Interventional2003-07-31Completed
An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation[NCT00166244]Phase 4901 participants (Actual)Interventional2003-05-31Completed
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies[NCT00072592]Phase 110 participants Interventional2003-10-31Completed
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis[NCT02626845]Phase 43 participants (Actual)Interventional2015-12-31Terminated (stopped due to Slow recruitment)
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis[NCT00001761]Phase 115 participants Interventional1998-02-28Completed
Treatment of Wegener's Granulomatosis With Cyclophosphamide[NCT00001155]Phase 2200 participants Interventional1976-02-29Completed
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.[NCT00751517]Phase 20 participants InterventionalActive, not recruiting
A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides[NCT00004567]Phase 275 participants Interventional2000-02-29Completed
Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis[NCT00001901]Phase 260 participants Interventional1999-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Deaths

Treatment Failure was adjudicated by a clinical endpoints committee (CEC) and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis (LN). (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

InterventionDeaths (Number)
Mycophenolate Mofetil (MMF)0
Azathioprine (AZA)1

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Participants With End-stage Renal Disease (ESRD)

Time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), was defined as any 1 the following: death, ESRD, sustained doubling of serum creatinine, renal flare (proteinuric or nephritic), or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. ESRD is defined as progression to chronic hemodialysis or renal transplant. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Interventionparticipants (Number)
Mycophenolate Mofetil (MMF)0
Azathioprine (AZA)3

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Participants With Sustained Doubling of Serum Creatinine

Sustained doubling of serum creatinine concentration is defined as the first serum creatinine value that is twice the mean of the lowest 2 values from screening to end of induction, as confirmed by a second serum creatinine value obtained at least 4 weeks after the initial doubling. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Interventionparticipants (Number)
Mycophenolate Mofetil1
Azathioprine5

Maintenance Phase: Participants With Major Extra-renal Flare

A major extra-renal flare is defined as a British Isles Lupus Assessment Group (BILAG) Score category A in one extrarenal organ or three organs with concurrent category B scores. BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Interventionparticipants (Number)
Mycophenolate Mofetil7
Azathioprine6

Induction Phase: Change From Baseline in Short-Form Health Survey (SF-36) Domain and Component Scores

The SF-36 is a 36 item quality of life questionnaire. The short-form version has eleven questions that permit the participant to rate how they feel that particular day. The SF-36 consists of eight scaled scores and two component scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 score with the higher scores indicating better quality of life. (NCT00377637)
Timeframe: Baseline and 24 weeks

,
InterventionScores on a scale (Mean)
Physical Component Summary [n=139, 137]Mental Component Summary [n=139, 137]Bodily Pain Score [n=141, 137]General Health Score [n=139, 137]Mental Health Score [n=141, 137]Physical functioning Score [n=141, 137]Role-Emotional Score [n=141, 137]Role-Physical Score [n=141, 137]Social Function Score [n=141, 137]Vitality Score [n=141, 137]
Intravenous Cyclophosphamide6.45.716.811.59.89.318.434.018.211.6
Mycophenolate Mofetil5.26.713.49.19.311.623.428.617.714.2

Induction Phase: Change From Baseline to Week 24 in 24-hour Urine Protein

24-hour urine protein was measured at Baseline and Week 24. (NCT00377637)
Timeframe: Baseline, Week 24

,
Interventionmg/day (Mean)
Baseline [n=180, 180]Week 24 [n= 150, 144]Change from Baseline to Week 24 [n= 146, 142]
Intravenous Cyclophosphamide4451.41831.6-2513.7
Mycophenolate Mofetil4208.91599.0-2510.6

Induction Phase: Change From Baseline to Week 24 in Serum Albumin

(NCT00377637)
Timeframe: Baseline, Week 24

,
Interventiong/L (Mean)
Baseline [n=184, 185]Week 24 [n=155, 151]Change from Baseline to Week 24 [n=154, 151]
Intravenous Cyclophosphamide28.638.39.0
Mycophenolate Mofetil30.538.47.5

Induction Phase: Change From Baseline to Week 24 in Serum Creatinine

(NCT00377637)
Timeframe: Baseline, Week 24

,
Interventionµmol/L (Mean)
Baseline [n= 184, 185]Week 24 [n= 155, 151]Change from Baseline to Week 24 [n= 154, 151]
Intravenous Cyclophosphamide92.783.5-5.1
Mycophenolate Mofetil108.677.6-18.9

Induction Phase: Change in Renal British Isles Lupus Assessment Group (BILAG) Score

"BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. The BILAG individual system summaries were calculated by a program supplied by ADS-Limathon (Sheffield, UK).~The score at baseline was compared to the score at the 24 week endpoint for each treatment group, reported here for the renal system." (NCT00377637)
Timeframe: Baseline, 24 weeks

,
InterventionPercentage of participants (Number)
Shift from Baseline=A to 24 Week Endpoint=AShift from Baseline=A to 24 Week Endpoint=BShift from Baseline=A to 24 Week Endpoint=CShift from Baseline=A to 24 Week Endpoint=DShift from Baseline=B to 24 Week Endpoint=AShift from Baseline=B to 24 Week Endpoint=BShift from Baseline=B to 24 Week Endpoint=CShift from Baseline=B to 24 Week Endpoint=DShift from Baseline=C to 24 Week Endpoint=AShift from Baseline=C to 24 Week Endpoint=BShift from Baseline=C to 24 Week Endpoint=CShift from Baseline=C to 24 Week Endpoint=DShift from Baseline=D to 24 Week Endpoint=AShift from Baseline=D to 24 Week Endpoint=BShift from Baseline=D to 24 Week Endpoint=CShift from Baseline=D to 24 Week Endpoint=D
Intravenous Cyclophosphamide27.134.824.99.40.01.11.70.00.00.60.00.00.00.00.60.0
Mycophenolate Mofetil17.139.233.15.50.01.72.21.10.00.00.00.00.00.00.00.0

Induction Phase: Number of Participants Achieving Complete Remission

Number of participants achieving complete remission as defined by return to normal serum creatinine, proteinuria ≤500 mg/24 hours and an inactive urinary sediment (absence of red blood cells, white blood cells or cellular or granular casts) after 24 weeks. (NCT00377637)
Timeframe: 24 weeks

,
Interventionparticipants (Number)
Complete Remission - YesComplete Remission - No
Intravenous Cyclophosphamide15170
Mycophenolate Mofetil16169

Induction Phase: Number of Patients Showing Treatment Response

Treatment response was adjudicated by a blinded clinical endpoints committee (CEC) and defined as: a) Decrease in proteinuria, defined as a decrease in the urine protein to creatinine ratio (UPCr) to <3 in subjects with baseline proteinuria ≥3 UPCr or a decrease in the UPCr by ≥50% in subjects with proteinuria <3 UPCr at Baseline, and b) Stabilization of serum creatinine or improvement. UPCr were derived from the 24 hour urine collection. Patients who did not show a treatment response at Week 24 or who withdrew earlier than Week 24 were considered non-responders. (NCT00377637)
Timeframe: 24 weeks

,
Interventionparticipants (Number)
ResponderNon-responder
Intravenous Cyclophosphamide9887
Mycophenolate Mofetil10481

Maintenance Phase: Events Contributing to the Primary Endpoint: Kaplan-Meier Estimates of Percentage of Participants Not Receiving Rescue Therapy

The primary efficacy parameter was the time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), defined as any of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to rescue treatment for each patient. The data presented are the percentage of participants who were rescue treatment free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

,
InterventionPercentage of participants (Number)
Start of Maintenance Phase to Month 3Month 3 to Month 6Month 6 to Month 9Month 9 to Month 12Month 12 to Month 15Month 15 to Month 18Month 18 to Month 21Month 21 to Month 24Month 24 to Month 27Month 27 to Month 30Month 30 to Month 33Month 33 to Month 36
Azathioprine99.195.193.091.988.487.183.183.181.780.378.875.9
Mycophenolate Mofetil10098.297.294.294.294.293.191.990.890.890.890.8

Maintenance Phase: Events Contributing to the Primary Endpoint: Kaplan-Meier Estimates of Percentage of Participants Renal Flare Free, by Time Interval

A proteinuric flare is defined as a doubling of the urine protein:creatinine ratio, and proteinuria ≥1 g/24 h in patients with urine protein ≤0.5 g/24 h at the end of the induction phase, or proteinuria ≥2 g/24 h if urine protein was >0.5 g/24 h at the end of the induction phase. A nephritic flare is defined as a 25% increase in serum creatinine accompanied by 1 or more of the following: (a) simultaneous doubling of the proteinuria reaching a minimum of 2 g/24 h (b) new/increased hematuria or (c) the appearance of cellular casts. All flares were adjudicated by a clinical endpoints committee. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

,
InterventionPercentage of participants (Number)
Start of Maintenance Phase to Month 3Month 3 to Month 6Month 6 to Month 9Month 9 to Month 12Month 12 to Month 15Month 15 to Month 18Month 18 to Month 21Month 21 to Month 24Month 24 to Month 27Month 27 to Month 30Month 30 to Month 33Month 33 to Month 36
Azathioprine97.290.387.285.082.879.278.075.574.274.272.970.1
Mycophenolate Mofetil98.294.690.887.887.886.886.886.886.886.885.685.6

Maintenance Phase: Kaplan-Meier Estimates of Percentage of Participants Treatment Failure Free, by Time Interval

Treatment Failure was adjudicated by a clinical endpoints committee and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to treatment failure for each patient. The data presented are the percentage of participants who were treatment-failure free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

,
InterventionPercentage of participants (Number)
Start of Maintenance Phase to Month 3Month 3 to Month 6Month 6 to Month 9Month 9 to Month 12Month 12 to Month 15Month 15 to Month 18Month 18 to Month 21Month 21 to Month 24Month 24 to Month 27Month 27 to Month 30Month 30 to Month 33Month 33 to Month 36
Azathioprine97.289.386.283.077.574.170.768.367.165.963.458.6
Mycophenolate Mofetil98.293.789.986.086.084.984.983.982.882.881.781.7

Reviews

10 reviews available for prednisone and Opportunistic Infections

ArticleYear
Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review.
    BMC infectious diseases, 2021, Jan-06, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Humans; Immunocompromised Host; Male; Middle Ag

2021
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
    World journal of gastroenterology, 2013, Jun-07, Volume: 19, Issue:21

    Topics: Acyclovir; Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antiviral

2013
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 54, Issue:6

    Topics: Antibodies, Monoclonal; Drug Therapy, Combination; Europe; Humans; Immunosuppressive Agents; Inflamm

2012
[Corticosteroid therapy for nephrotic syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:10

    Topics: Drug Resistance; Drug Therapy, Combination; Femur Head Necrosis; Fractures, Spontaneous; Humans; Imm

2004
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents

1995
Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. Longcope Firm of the Osler Housestaff.
    The Journal of allergy and clinical immunology, 1994, Volume: 94, Issue:1

    Topics: Adult; Antibodies; Drug Resistance; Drug Therapy, Combination; Gastroenteritis; Humans; Hypereosinop

1994
Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy.
    The Mount Sinai journal of medicine, New York, 1999, Volume: 66, Issue:2

    Topics: Anti-Inflammatory Agents; Cytomegalovirus Infections; Fatal Outcome; Humans; Immunocompromised Host;

1999
Hodgkin's disease: clinical presentation and treatment.
    Cancer treatment and research, 2001, Volume: 104

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

2001
Allogeneic stem cell transplantation for Evans syndrome.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Autoimmune Di

2001
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
    Revue de pneumologie clinique, 1991, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine;

1991

Trials

11 trials available for prednisone and Opportunistic Infections

ArticleYear
A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
    Acta haematologica, 2016, Volume: 136, Issue:2

    Topics: Adult; Aged; Dexamethasone; Drug Administration Schedule; Follow-Up Studies; Glucocorticoids; Humans

2016
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combin

2010
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
    European journal of haematology, 2011, Volume: 86, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu

2011
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
Reduced exposure to calcineurin inhibitors in renal transplantation.
    The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal

2007
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:5

    Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;

1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:5

    Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;

1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:5

    Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;

1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:5

    Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;

1995
A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:6

    Topics: Anti-Infective Agents; Azathioprine; Cadaver; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Graft

1996
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R

1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R

1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R

1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R

1999
Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.
    Transplantation, 2001, Mar-15, Volume: 71, Issue:5

    Topics: Adolescent; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection

2001
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.
    Transplantation proceedings, 2002, Volume: 34, Issue:1

    Topics: Adrenal Cortex Hormones; Age Factors; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studi

2002
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Annals of internal medicine, 1991, Jun-01, Volume: 114, Issue:11

    Topics: Adult; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Female;

1991
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica

1988

Other Studies

102 other studies available for prednisone and Opportunistic Infections

ArticleYear
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2022, Volume: 20, Issue:7

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Non-Small-Cell Lung; Humans; Immunocomprom

2022
[Cutaneous Scedosporium apiospermum infection in a patient on long-term systemic corticosteroids].
    Annales de dermatologie et de venereologie, 2019, Volume: 146, Issue:11

    Topics: Aged, 80 and over; Dermatomycoses; Glucocorticoids; Hand; Humans; Immunocompromised Host; Male; Myco

2019
Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Antibiotics, Antineoplastic; Bacteremia; BK Virus; Cardiomyopathy, Dilated; Cardiotoxicity; COVID-19

2020
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
    Cancer medicine, 2021, Volume: 10, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Beijing; Female; Glucocorticoids; Humans; Immune Checkpoint Inhibito

2021
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
    JAAPA : official journal of the American Academy of Physician Assistants, 2021, Feb-01, Volume: 34, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromis

2021
Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis.
    The American journal of case reports, 2017, Dec-21, Volume: 18

    Topics: Colitis, Ulcerative; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agen

2017
Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone.
    Practical neurology, 2019, Volume: 19, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Brain; Humans; Immunocompromised Host; Male; Nocardia Infections; Op

2019
A case of severe cutaneous
    BMJ case reports, 2019, Jan-10, Volume: 12, Issue:1

    Topics: Aged; Animals; Anti-Bacterial Agents; Crohn Disease; Fishes; Humans; Male; Mycobacterium Infections,

2019
Invasive fungal infections in renal transplant recipients: about 11 cases.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Coinfection; Female; Graft Rejection; Humans; Immunocompromised Host;

2013
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2014, Volume: 226, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil

2014
[Chronic ulcer in nasal vestibule].
    Medicina clinica, 2014, Jul-07, Volume: 143, Issue:1

    Topics: Chronic Disease; Diagnosis, Differential; Female; Granuloma, Lethal Midline; Humans; Immunocompromis

2014
Opportunistic infections in patients with pemphigus.
    Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus

2014
Aggressive Cunninghamella pneumonia in an adolescent.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis

2014
Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pharmacotherapy, 2015, Volume: 35, Issue:8

    Topics: Adult; Animals; Antilymphocyte Serum; Blood Cell Count; Drug Therapy, Combination; Female; Graft Rej

2015
[Pulmonary nodules in a patient on long-term steroid treatment].
    Praxis, 2008, Jul-30, Volume: 97, Issue:15

    Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Mycobacterium Infect

2008
[Pneumocystis pneumonia among patients with systemic diseases].
    Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:2

    Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Granulo

2009
[Mycobacterium neoaurum bacteremia in an immunodepressed patient].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1

    Topics: Adult; Azathioprine; Bacteremia; Colitis, Ulcerative; Female; Humans; Immunocompromised Host; Immuno

2009
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:2

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Epidemiologic M

2010
Central airways obstruction due to Aspergillus fumigatus after lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:5

    Topics: Airway Obstruction; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Diagnosis, Differential;

2009
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
    JAMA, 2009, Jun-24, Volume: 301, Issue:24

    Topics: Anti-Infective Agents; Antifungal Agents; Glucocorticoids; Humans; Immunocompromised Host; Leukemia,

2009
Swine H1N1 influenza in a post liver transplant patient.
    The New Zealand medical journal, 2009, Oct-09, Volume: 122, Issue:1304

    Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Disease Outbreaks; Drug Resistance,

2009
Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Therapy, Combina

2010
Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.
    Infection, 2010, Volume: 38, Issue:4

    Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosup

2010
Borreliosis in a patient treated with anti-TNFα therapy: first case.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:3

    Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Doxycycline; Drug Therapy, Combi

2011
[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)].
    Praxis, 2010, Jun-23, Volume: 99, Issue:13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2010
Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:5

    Topics: Aged; Colitis, Ulcerative; Colonic Neoplasms; Herpesvirus 8, Human; Humans; Immunocompromised Host;

2010
Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis.
    Joint bone spine, 2011, Volume: 78, Issue:4

    Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthr

2011
PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators.
    Muscle & nerve, 2011, Volume: 43, Issue:6

    Topics: Chemoprevention; Dermatomyositis; Humans; Inflammation Mediators; Lymphopenia; Male; Middle Aged; Op

2011
Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab.
    British journal of haematology, 2011, Volume: 154, Issue:4

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv

2011
Cutaneous fusariosis developing in a post-irradiation site.
    Dermatology online journal, 2011, May-15, Volume: 17, Issue:5

    Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Human

2011
Nocardia infection in a renal transplant recipient.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:6

    Topics: Acetamides; Anti-Infective Agents; Antifungal Agents; Cyclosporine; Drug Therapy, Combination; Epidu

2011
Pneumocystis pneumonia in patients with immunobullous dermatoses.
    International journal of dermatology, 2011, Volume: 50, Issue:9

    Topics: Aged; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middl

2011
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
    Annals of hematology, 2013, Volume: 92, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2013
Fatal invasive aspergillosis of the larynx.
    European journal of haematology, 2013, Volume: 90, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Consolidation Chemother

2013
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2002, Volume: 8, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Graft v

2002
[Atypical cytomegalovirus in renal transplantation: a new form of presentation].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22, Issue:4

    Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Disease Susceptibility; Duodenal Ulcer; Gastroint

2002
Nocardiosis presenting as an anterior mediastinal mass in a patient with sarcoidosis.
    The Mount Sinai journal of medicine, New York, 2002, Volume: 69, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Mediastinal Diseases; Nocardia Infections; Opportun

2002
Pneumocystis carinii in a patient with hypercalcemia and renal failure secondary to sarcoidosis.
    Wiener klinische Wochenschrift, 2002, Sep-30, Volume: 114, Issue:17-18

    Topics: CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Hypercalcemia; Immune Tolerance; Male; Midd

2002
[Pancytopenia after viral infection in St. n. malignant lymphoma].
    Praxis, 2003, Jan-22, Volume: 92, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality The

2003
Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy.
    Medicine, 2003, Volume: 82, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes;

2003
Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy.
    The Journal of dermatology, 2003, Volume: 30, Issue:4

    Topics: Aged; Biopsy, Needle; Cytomegalovirus Infections; Fever; Follow-Up Studies; Ganciclovir; Humans; Imm

2003
Ambivalence of CD4 lymphocytopenia in sarcoidosis.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2003, Volume: 20, Issue:1

    Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Glucocorticoids; Humans; Male; Opportunistic Infections

2003
Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia.
    Postgraduate medical journal, 2004, Volume: 80, Issue:942

    Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dyspnea; Fatal

2004
[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
    Anales de medicina interna (Madrid, Spain : 1984), 2004, Volume: 21, Issue:1

    Topics: Aged; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Aspergillosis; Aspergillus; Auto

2004
Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease.
    Thorax, 2004, Volume: 59, Issue:7

    Topics: Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Diagnosis, Differential; Humans; Immunocompro

2004
Disseminated histoplasmosis presenting as pancytopenia in a methotrexate-treated patient.
    American journal of hematology, 2004, Volume: 77, Issue:1

    Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Male; Met

2004
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Oct-26, Volume: 171, Issue:9

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Biopsy, Needle; Crohn Disease; Drug Therapy, Combinat

2004
[Endogenous Candida endophthalmitis combined with severe general diseases].
    Klinische Monatsblatter fur Augenheilkunde, 2005, Volume: 222, Issue:3

    Topics: Aged; Amphotericin B; Anterior Chamber; Antifungal Agents; Candidiasis; Endophthalmitis; Female; Fun

2005
Fungal infections as a complication of therapy for sarcoidosis.
    QJM : monthly journal of the Association of Physicians, 2005, Volume: 98, Issue:6

    Topics: Antifungal Agents; Cryptococcosis; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotr

2005
Could Candida dubliniensis be involved in lung fungus balls?
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C

2005
Mycophenolate mofetil in dermatomyositis: is it safe?
    Neurology, 2006, Apr-25, Volume: 66, Issue:8

    Topics: Adult; Aged; Bronchopneumonia; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combinat

2006
[Cutaneous leishmaniasis in polymyositis].
    La Revue de medecine interne, 2006, Volume: 27, Issue:7

    Topics: Adult; Animals; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Immunoglobulins, Intraven

2006
[Cryptococcal disease and immunosuppressive treatment].
    Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:9

    Topics: Aged, 80 and over; Disease Susceptibility; Female; HIV Seronegativity; Humans; Immunocompromised Hos

2006
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2007, Volume: 13, Issue:3

    Topics: Adalimumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents

2007
Phaeohyphomycosis and Mycobacterium fortuitum abscesses in a patient receiving corticosteroids for sarcoidosis.
    Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:2 Pt 1

    Topics: Abscess; Adult; Dermatomycoses; Female; Humans; Immunocompromised Host; Mycobacterium Infections, No

1995
Invasive aspergillosis. A complication of treatment of temporal arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1995, Volume: 15, Issue:1

    Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Brain; Fatal Outcome; Female; Giant C

1995
Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:1

    Topics: Aged; Aged, 80 and over; Bacterial Infections; Esophagitis; Female; Humans; Immunocompromised Host;

1995
Pneumocystis carinii pneumonia after liver transplantation in adults.
    Clinical transplantation, 1994, Volume: 8, Issue:6

    Topics: Adult; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Diseases; Liver Function Te

1994
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
    American journal of respiratory and critical care medicine, 1995, Volume: 151, Issue:3 Pt 1

    Topics: Female; Granulomatosis with Polyangiitis; Humans; Immunosuppression Therapy; Immunosuppressive Agent

1995
Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:3

    Topics: Adult; Aspergillosis; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female;

1995
[Eosinophilic endomyocarditis post partum or pregnancy-related cardiomyopathy].
    Herz, 1994, Volume: 19, Issue:3

    Topics: Adult; Azathioprine; Biopsy; Combined Modality Therapy; Cytomegalovirus Infections; Diagnosis, Diffe

1994
Late listeriosis after fludarabine plus prednisone treatment.
    British journal of haematology, 1994, Volume: 87, Issue:2

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans;

1994
Development of panhypogammaglobulinaemia in a patient with systemic lupus erythematosus.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:6

    Topics: Administration, Oral; Adult; Agammaglobulinemia; Azathioprine; Bacterial Infections; Cyclophosphamid

1994
[Cutaneous Alternaria infection occurring in the course of a treated pemphigus].
    Annales de pathologie, 1994, Volume: 14, Issue:3

    Topics: Aged; Alternaria; Dermatomycoses; Humans; Male; Opportunistic Infections; Pemphigus; Prednisone

1994
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1994, Volume: 45, Issue:5

    Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma

1994
[Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia].
    Revista medica de Chile, 1993, Volume: 121, Issue:12

    Topics: Bronchoalveolar Lavage Fluid; Cyclophosphamide; Female; Humans; Lung; Lupus Erythematosus, Systemic;

1993
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
    The Journal of rheumatology, 1994, Volume: 21, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Connective Tissue Diseases; Cyclophosphamide; Female; Humans; Immuno

1994
De novo hypertension after liver transplantation.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:2

    Topics: Adult; Azathioprine; Cyclosporine; Humans; Hypertension; Immunosuppression Therapy; Labetalol; Liver

1993
Wegener granulomatosis in children and adolescents: clinical presentation and outcome.
    The Journal of pediatrics, 1993, Volume: 122, Issue:1

    Topics: Adolescent; Adult; Age Factors; Child; Cyclophosphamide; Eye Diseases; Female; Follow-Up Studies; Gl

1993
Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole.
    Clinical and experimental dermatology, 1993, Volume: 18, Issue:2

    Topics: Aged; Aged, 80 and over; Alternaria; Dermatomycoses; Hand Dermatoses; Humans; Male; Nephrotic Syndro

1993
Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris.
    Clinical and experimental dermatology, 1996, Volume: 21, Issue:4

    Topics: Aged; Glucocorticoids; Humans; Keratitis, Herpetic; Male; Opportunistic Infections; Pemphigus; Predn

1996
Opportunistic infections in patients with temporal arteritis treated with corticosteroids.
    Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Bacteremia; Cryptococcosis; Fatal Outcome; Giant Cell Arteritis; Hum

1997
Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:5 Pt 2

    Topics: Aged; Aged, 80 and over; Azathioprine; DNA, Viral; Female; Herpesvirus 8, Human; Humans; Immunosuppr

1997
Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir.
    Bone marrow transplantation, 1997, Volume: 20, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation

1997
Disseminated Rhodococcus equi and Nocardia farcinica infection in a patient with sarcoidosis.
    The Journal of infection, 1998, Volume: 36, Issue:1

    Topics: Actinomycetales Infections; Glucocorticoids; HIV Seronegativity; Humans; Immunocompromised Host; Mal

1998
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.
    Chest, 1998, Volume: 113, Issue:5

    Topics: Anti-Infective Agents; Antifungal Agents; Drug Therapy, Combination; Female; Glucocorticoids; HIV In

1998
Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Azathioprine; Bone Marrow Cells; Drug Carriers; Drug Thera

1998
Nocardiosis in a recently transplanted renal patient.
    Clinical nephrology, 1998, Volume: 50, Issue:2

    Topics: Diabetes Complications; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressiv

1998
Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
    Annals of internal medicine, 1998, Oct-01, Volume: 129, Issue:7

    Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combine

1998
Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
    Clinical transplantation, 1998, Volume: 12, Issue:5

    Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Female; Humans;

1998
Disseminated histoplasmosis and Wegener's granulomatosis.
    Southern medical journal, 1998, Volume: 91, Issue:12

    Topics: Adult; Cyclophosphamide; Fatal Outcome; Female; Glucocorticoids; Granulomatosis with Polyangiitis; H

1998
Clinical conference on management dilemmas: progressive pneumonia in a patient receiving long-term steroid therapy.
    Chest, 1999, Volume: 115, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy

1999
Primary subcutaneous nocardial infection in a SLE patient.
    Lupus, 1999, Volume: 8, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Immunocompromised Host; Lupus Erythematosus, System

1999
[Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient].
    Annales de dermatologie et de venereologie, 2001, Volume: 128, Issue:2

    Topics: Biopsy; Cyclosporine; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Live

2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo

2001
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2001. Acute febrile respiratory illness in a 57-year-old man with recurrent pulmonary disorders.
    The New England journal of medicine, 2001, Nov-22, Volume: 345, Issue:21

    Topics: Anti-Inflammatory Agents; Cough; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Fever; H

2001
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
    International journal of hematology, 2002, Volume: 75, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive

2002
Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:4

    Topics: Amikacin; Anemia; Anti-Bacterial Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor;

2002
Complications of corticosteroid therapy in presumptive temporal arteritis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1976, Volume: 11, Issue:2

    Topics: Aged; Autopsy; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Opportunistic Infections; Prednis

1976
Cytomegalovirus infection in children with blood diseases.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C

1992
Pneumonia and pneumonitis in childhood malignancy.
    Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:3

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; C

1992
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease.
    The American journal of medicine, 1992, Volume: 93, Issue:1

    Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Asthma; Female; Forced Expiratory Vol

1992
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin

1991
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Wegener granulomatosis: an analysis of 158 patients.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-

1992
Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine.
    The Journal of rheumatology, 1991, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Animals; Arthritis, Infectious; Azathioprine; Connective Tissue Diseases; Drug Th

1991
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
    Archives of dermatology, 1990, Volume: 126, Issue:1

    Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle

1990
Multiple brain abscesses from isolated cerebral mucormycosis.
    Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:5

    Topics: Adult; Brain Abscess; Cyclophosphamide; Female; Frontal Lobe; Humans; Lupus Erythematosus, Systemic;

1990
Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Transplantation, 1989, Volume: 47, Issue:1

    Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Graft Rejec

1989
Serious infectious complications of corticosteroid therapy for COPD.
    Chest, 1989, Volume: 95, Issue:6

    Topics: Aged; Aged, 80 and over; Female; Humans; Lung Diseases, Obstructive; Male; Methylprednisolone; Middl

1989
Pulmonary infections in renal transplantation patients treated with cyclosporine.
    Radiology, 1988, Volume: 167, Issue:1

    Topics: Adult; Cyclosporins; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Male; Middl

1988
A prospective study on infection with cytomegalovirus in renal allograft recipients immunosuppressed with cyclosporine A and low dose prednisone.
    Scandinavian journal of infectious diseases, 1987, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Antibodies, Viral; Child; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infectio

1987
First month cyclosporine A sparing in renal transplantation.
    Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 3

    Topics: Creatinine; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft Reje

1988